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Purpose: To investigate changes in cytokine levels in tears of type 2 diabetics with or without retinopathy.
Methods: Tears were collected from 15 type 2 diabetics without retinopathy (DNR), 15 patients with retinopathy (DR),
and 15 age and gender matched non-diabetic controls. Tear concentrations of 27 cytokines were measured by multiplex
bead immunoassay. Cytokine differences between groups, ratios of type-1 T helper (Th1)/type-2 T helper (Th2) cytokines
and anti-angiogenic/pro-angiogenic cytokines were analyzed statistically.
Results: The most abundant cytokine detected in tears was interferon-induced protein-10 (IP-10). In comparison with
controls, IP-10 and monocyte chemoattracant protein-1 (MCP-1) levels were significantly elevated in DR (p=0.016 and
0.036, respectively) and DNR groups (p=0.021 and 0.026, respectively). Interleukin-1 (IL-1) receptor antagonist (IL-1ra)
levels were significantly increased in DNR (p=0.016). Th1/Th2 cytokines interferon-gamma (IFN-γ)/IL-5 and IL-2/IL-5
ratios were significantly increased in DR compared to controls (p=0.037 and 0.031, respectively). Anti-angiogenic/
angiogenic cytokines IFN-γ/MCP-1 and IL-4/MCP-1 ratios in DR and DNR were significantly decreased compared to
controls (p<0.05). IL-4/IL-8 and IL-12p70/IL-8 ratios were also significantly decreased in DR compared to controls
(p=0.02 and 0.045, respectively). No significant correlation was demonstrated between tear cytokine concentrations and
glycosylated hemoglobin (HbA1c) or fasting plasma glucose (FPG).
Conclusions: Diabetic tears exhibited elevated levels of IP-10 and MCP-1. The Th1/Th2 cytokine balance may shift to
a predominantly Th1 state in DR patients. Pro-angiogenic cytokines are more highly represented than anti-angiogenic
cytokines in the tears of diabetic patients.
Diabetes  mellitus  (DM)  can  induce  various  kinds  of
ocular  complications  such  as  diabetic  retinopathy  (DR),
neovascular glaucoma, cataract, refractory deviations, ptosis
and palsy of the oculomotorius nerve [1-4]. DR, one of the
most common causes of blindness in western populations, is
the most frequent diabetic microvascular disease [5]. During
the first two decades of disease, nearly all patients with type
1 DM and >60% of patients with type 2 DM develop DR [5].
Although the pathogenesis of DR is yet not completely
elucidated, there is increasing evidence that the inflammatory
process may play a role. Elevated levels of inflammatory
cytokines, chemokines and growth factors can be detected in
vitreous  fluids  and  aqueous  humor  of  patients  with  DR
[6-11]. These upregulated inflammatory cytokines and other
inflammatory mediators, which may lead to persistent low-
grade inflammation and influx of leukocytes, are proposed to
contribute to DR-associated damage of the eyes in diabetes
patients [12].
The  ocular  surface  is  also  affected  by  DM.  Reduced
corneal sensitivity and altered tear quantity and quality have
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been reported in diabetic patients [13]. There are significant
correlations between the grade of DR and degree of corneal
epithelial  fragility  or  corneal  sensitivity  [14,15].  Dry  eye
syndrome, an ocular surface disease, is frequently found in
diabetic patients. The severity of the dry eye disease has been
found to be correlated with the severity of DR [16,17].
Many  studies  have  demonstrated  the  presence  of
cytokines in tears. Elevated levels of inflammatory cytokines
have been reported in tears from various ocular diseases [18,
19]. So far there have been no reports regarding the changes
of cytokines in tears of diabetic patients with retinopathy. In
the  present  study  we  report  the  results  of  analysis  of  27
cytokines in tears obtained from type 2 diabetic patients with
or without retinopathy.
METHODS
Study subjects: All diabetic patients (hospitalized) and non-
diabetic  subjects  were  recruited  from  the  Department  of
Endocrinology, First Hospital Affiliated, Medical School of
Xi’an, Jiaotong University, Xi’an, China. All were ethnic
Chinese,  residing  in  the  Shaanxi  province,  China.  Before
enrolment  in  the  study,  all  subjects  signed  an  informed
consent  after  explanation  of  the  nature  and  possible
consequences of the study. All experimental protocols were
reviewed and approved by the hospital Human Ethics Review
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2931Committee and complied with the Declaration of Helsinki for
Experimentation on Humans, 1975 and revised in 1983.
DM was diagnosed according to the 1999 World Health
Organization (WHO) criteria. DR was diagnosed on the basis
of fundus examination and fluorescein angiography. Fifteen
type  2  diabetic  patients  without  retinopathy  (DNR),  15
patients  with  retinopathy  (DR),  and  15  gender-  and  age-
matched  non-diabetic  controls  (with  fasting  finger  blood
glucose level below 5.6 mmol/l) were recruited. None of the
subjects had clinically detectable ocular infection, age-related
macular degeneration, glaucoma or cataract. The duration of
diabetes,  fasting  plasma  glucose  (FPG)  and  glycosylated
hemoglobin (HbA1c) levels, measured by standard methods
used  in  pathology  laboratories,  were  recorded  and  no
significant differences between DNR and DR groups were
found (Table 1).
Sample collection: Open eye basal tear samples were collected
using a blunt glass capillary tube to obtain 5–10 µl tears from
the outer canthus of the eyes [20]. Care was taken to minimize
stimulation to the eyes to avoid collecting reflex tears. The
tear samples were immediately stored at −80 °C until use,
except for a period of transportation (20 h) from Xi’an, China
to Sydney, Australia. During this time the samples were kept
frozen in ice packs.
Total protein concentrations and immunoglobulin A (IgA)
assay  in  tear  samples:  Total  protein  concentrations  were
assayed  in  each  tear  sample  using  Lavapep  protein
quantitation kits (Fluorotechnics, Sydney, Australia) and IgA
concentration  was  quantified  using  an  enzyme-linked
immunosorbent  assay  (ELISA;  Bethyl  Laboratories,
Montgomery,  AL),  each  according  to  manufacturer’s
instructions.
Multiplex analysis of cytokines in tears using the Bio-Plex
system: Twenty seven cytokines (interleukin-1β [IL-1β], IL-1
receptor antagonist [IL-1ra], IL-2, −4, −5, −6, −7, −8, −9, −10,
−12p70, −13, −15, −17, tumor necrosis factor-alpha [TNF-
α], interferon-gamma [IFN-γ], granulocyte-monocyte colony-
stimulating factor [GM-CSF], granulocyte colony stimulating
factor [G-CSF], platelet-derived growth factor-BB [PDGF-
BB],  basic  fibroblast  growth  factor  [FGF-b],  vascular
endothelial  growth  factor  [VEGF],  MCP-1,  macrophage
inflammatory  protein  −1α,  −1β  [MIP-1α,  MIP-1β],
EOTAXIN,  interferon-induced  protein-10  [IP-10],  and
regulated  upon  activation,  normal  T-cell  expressed  and
presumably secreted [RANTES]) in each tear sample were
detected  using  multiplex  bead  analysis  (Bio-Plex  Human
Cytokine 27-plex panel; Bio-Rad, Hercules, CA). The tear
samples  were  diluted  20-fold  using  the  sample  diluent
supplied in the kit. Standard curves were generated by using
the reference cytokine sample supplied in the kit and were
used to calculate the cytokine concentrations in tear samples.
For cytokine recovery rate tests, 133 µl of a 195 fold
dilution of the reconstituted cytokine standard stock solution
in sample diluent was mixed with 7 µl of a pooled tear sample
(20-fold dilution as for other tear samples). The cytokine
concentrations in this mixture, in the 195 fold dilution, and in
the  20-fold  diluted  pooled  tears  in  sample  diluents  were
assayed (50 µl/well). The recovery rate for each cytokine was
calculated by the following equation:
Recovery rate = A/((B × 133 + C × 7)/140) × 100%
In the equation, A is the detected cytokine concentration of
the mixture of standard and the tear sample; B is the detected
cytokine concentration of the 195 fold standard dilution, C is
the detected cytokine concentration of the pooled tear sample.
Statistical analysis: Data were expressed as mean±standard
error (SE) and analyzed using the statistical package for social
sciences (SPSS; SPSS Inc., Chicago, IL). The differences
between the three groups were assessed by one-way ANOVA
with  a  post-hoc  analysis  (Bonferroni  test).  For  statistical
analysis,  variables  with  skewed  distribution  (IL-1β,  IL-2,
IL-4,  IL-6,  IL-7,  IL-9,  IL-10,  IL-12p70,  IL-13,  IL-15,
EOTAXIN, FGF-b, G-CSF, GM-CSF, IFN-γ, IP-10, MCP-1,
MIP-1β,  PDGF-BB,  and  RANTES)  were  square  root
transformed; the variables for other cytokines (IL-1ra, IL-5,
IL-8,  and  VEGF)  were  logarithmically  transformed.
Differences  were  considered  significant  at  p<0.05.
Correlations  between  HbA1c  or  FPG  levels  in  plasma,
duration of diabetes and single cytokines or cytokine ratios
were  calculated  by  Pearson  correlation  coefficient.
Differences were considered significant at p<0.01.
TABLE 1. CLINICAL CHARACTERISTICS OF DIABETIC PATIENTS AND NON-DIABETIC CONTROLS.
Parameters Controls DNR DR
Sex (M/F) 15 (8/7) 15 (8/7) 15 (7/8)
Age (years) 59.00±2.42 61.27±1.95 61.07±2.16
Diabetic duration (years) _ 8.04±1.74 9.00±1.15
FPG (mmol/l) _ 9.14±0.62 8.24±0.87
HbA1c (%) _ 10.04±0.63 9.89±0.68
         In the table, Controls are non-diabetic controls; DR are type 2 diabetic patients with retinopathy; and DNR are type 2 diabetic
         patients without retinopathy. Data are expressed as mean±SEM.
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Total protein and IgA levels in tears: In comparison with
control  subjects  (9.4±0.8  mg/ml),  tear  total  protein
concentrations in DR (14.8±1.5 mg/ml, p=0.014) and DNR
group (13.6±1.3 mg/ml, p=0.044) were significantly elevated.
Difference between DR and DNR groups was not significant.
No  statistical  differences  were  found  for  tear  IgA  levels
among DR (685.3±56.6 µg/ml), DNR (615.2±54.9 µg/ml),
and control groups (531.4±65.0 µg/ml).
Tear cytokines: To test the effect of the tear matrix on the
assay, the recovery rate for each cytokine was measured by
adding in the same amount of tear fluid to 195 fold diluted
standard solution. The results are listed in Table 2. For 20 of
the 27 cytokines the recovery rates were between 80%–120%.
The cytokines outside this recovery range were PDGF-BB
(66%), IL-12p70 (78%), IL-15 (68%), FGF-b (175%), GM-
CSF (53%), MIP-1α (74%), and G-CSF (27%).
When the threshold for cytokine detection was set at
mean + (2×SD) of the control (blank) wells, positive detection
rates were more than 80% for 24 cytokines (Table 2). The
positive  detection  rates  for  other  3  cytokines  were  20%
(IL-17), 27% (TNF-α), and 60% (MIP-1α). Due to the low
detection rates/concentrations, these three cytokines were not
included in statistical analysis. The most abundant cytokines
(mean≥200 pg/ml; Table 2) detected in non-diabetic controls
were IP-10 (10,466.7 pg/ml), IL-1ra (3,988.7 pg/ml), IFN-γ
(1,463.0 pg/ml), IL-9 (539.4 pg/ml), PDGF-BB (532.4 pg/ml),
GM-CSF (465.8 pg/ml), FGF-b (355.8 pg/ml), G-CSF (324.4
pg/ml)  and  VEGF  (221.0  pg/ml).  The  levels  of  all  other
cytokines were below 200 pg/ml (Table 2).
In  comparison  with  non-diabetic  controls,  IP-10  and
MCP-1 levels were significantly elevated in DR (p=0.016 and
p=0.036,  respectively)  and  DNR  groups  (p=0.021  and
p=0.026,  respectively).  IL-1ra  levels  were  significantly
elevated  in  DNR  compared  to  controls  (p=0.016).  No
statistical differences were found between DR and DNR for
any cytokines (Table 2).
Th1/Th2  cytokine  ratios  in  tears:  Ratios  between  Th1
cytokines (IL-2, IL-12p70, and IFN-γ) and Th2 cytokines
(IL-4, IL-5, IL-6, IL-10, and IL-13) in tears were calculated
(Figure 1). IL-2/IL-5 and IFN-γ /IL-5 ratios were found to be
significantly  higher  in  DR  (36.3±8.9  and  643.8±152.5,
respectively; Figure 1) compared to those in non-diabetic
controls  (14.1±2.2,  p=0.031  and  254.45±60.1,  p=0.037,
respectively).  These  ratios  in  DNR  were  not  significantly
different to either non-diabetic controls or DR subjects. No
significant differences were observed in the ratios of IL-2/
IL-4,  IL-2/IL-6,  IL-2/IL-10,  IL-2/IL-13,  IL-12p70/IL-4,
TABLE 2. RECOVERY (%) AND POSITIVE DETECTION RATES (%) FOR EACH CYTOKINE IN THE TEAR SAMPLES AND CONCENTRATIONS (PG/ML) OF TEAR
CYTOKINES IN DIABETIC PATIENTS AND NON-DIABETIC CONTROLS.
      Concentration (pg/ml)
Cytokines Recovery Positive detection rates Controls DNR DR
IL-1β 93 100 20.0±2.8 20.9±3.6 16.7±3.2
IL-1ra 113 100 3988.7±685.0 9641.7±1923.9* 7409.8±1506.8
IL-2 91 98 105.1±13.4 108.0±17.1 111.2±14.9
IL-4 95 100 14.6±1.4 15.7±2.2 13.0±1.5
IL-5 100 93 15.0±4.0 10.8±2.6 16.7±8.4
IL-6 90 100 64.7±8.8 67.4±11.3 63.3±12.3
IL-7 84 100 106.9±8.2 117.3±12.9 100.1±8.7
IL-8 93 100 54.3±7.2 64.8±7.6 87.3±26.1
IL-9 103 98 539.4±61.2 658.2±87.4 636.0±107.3
IL-10 97 93 31.6±3.9 35.0±6.1 25.7±5.5
IL-12p70 78 100 142.7±19.9 138.3±27.7 99.2±22.0
IL-13 94 100 40.4±5.3 39.54±7.3 31.0±6.3
IL-15 68 84 25.5±3.2 29.7±5.2 20.1±3.6
IFN-γ 91 100 1463.0±158.8 1612.8±228.2 1957.50±166.1
G-CSF 27 100 324.4±32.2 370.7±49.4 319.4±35.0
GM-CSF 53 80 465.8±42.1 486.9±70.0 455.8±46.1
FGF-b 175 93 355.8±38.0 398.1±53.1 344.6±49.6
PDGF-BB 66 96 532.4±65.7 653.7±96.4 512.2±72.5
VEGF 99 100 221.0±16.7 296.1±22.5 270.7±40.2
EOTAXIN 100 100 178.3±14.1 185.1±20.9 170.1±14.7
IP-10 108 100 10466.7±1178.5 14201.4±835.6* 14410.8±901.3†
MCP-1 90 87 61.0±7.2 91.2±6.6* 92.2±10.4†
MIP-1β 113 96 145.7±15.0 172.8±19.7 205.9±66.0
RANTES 110 100 48.1±5.9 51.0±7.3 35.4±4.6
        Data were expressed as mean±SEM. The asterisk indicates a p<0.05 DNR versus Controls and the dagger indicates a p<0.05
        DR versus Controls.
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IL-13, IFN-γ/IL-4, IFN-γ/IL-6, IFN-γ/IL-10, or IFN-γ/IL-13
among the three groups.
Ratios of anti-angiogenic and pro-angiogenic cytokines in
tears:  To  explore  the  anti-angiogenic/pro-angiogenic
cytokine  profiles,  the  ratios  of  each  potentially  anti-
angiogenic  cytokine  (IL-1ra,  IP-10,  IFN-γ,  IL-4,  IL-10,
IL-12p70,  and  IL-13)  to  each  potentially  pro-angiogenic
cytokine (IL-1β, MCP-1, EOTAXIN, RANTES, IL-8, VEGF,
FGF-b, G-CSF, GM-CSF, PDGF-BB, IL-2, IL-6, and IL-15)
in tears were calculated. The ratios of IFN-γ/MCP-1, and IL-4/
MCP-1  in  DR  (15.64±1.81  and  0.16±0.02)  and  DNR
(17.58±2.38  and  0.17±0.02)  were  significantly  decreased
compared with those in non-diabetic controls (25.26±2.14 and
0.26±0.02,  both  p<0.05),  indicating  a  potentially  pro-
angiogenic environment in the ocular surface of the diabetic
patients. The ratios of IFN-γ/IL-8, IL-4/IL-8, and IL-12p70/
IL-8 were decreased in DR compared with those in non-
Figure 1. The ratios of Th1/Th2 cytokines in tears of non-diabetic
controls, DNR, and DR. Data expressed as mean±SEM A: IL-2/ Th2
(IL-4, IL-5, IL-6, IL-10, and IL-13) ratios. B: IL-12p70/ Th2 (IL-4,
IL-5, IL-6, IL-10, and IL-13) ratios. C: IFN-γ/ Th2 (IL-4, IL-5, IL-6,
IL-10, and IL-13) ratios. The asterisk indicates a p<0.05 versus non-
diabetic controls.
diabetic  controls  (20.89±2.59  versus  29.44±2.08,  p=0.06;
0.20±0.02 versus 0.30±0.02, p=0.02 and 1.67±0.42 versus
3.29±0.57,  p=0.045,  respectively),  again  indicating  a
potentially  pro-angiogenic  environment.  These  results  are
summarized in Figure 2. No differences were found for ratios
of the other anti-angiogenic and angiogenic cytokines among
the three groups.
Correlation between cytokine profiles and disease phenotype:
Correlation analysis showed that IL-2, IL-4, IL-7, EOTAXIN,
and IFN-γ concentrations in tears were negatively correlated
with duration of diabetes, i.e., the shorter the duration of
diabetes  the  higher  the  cytokine  concentration.  The
correlation coefficients and p values are summarized in Table
3. There were no other significant correlations for the analysis
using single cytokine levels or the ratios. No correlation was
demonstrated between tear cytokine concentrations and serum
HbA1c or FPG levels.
DISCUSSION
There is much debate from various studies regarding cytokine
levels in human tears [21-24]. Whether these inconsistencies
result from the use of subjects of different ethnicities (and
perhaps diet), age, and/or different detection methods remain
to be investigated. In this study, multiplex bead immunoassay
was used because of its capacity to quantify multiple cytokines
simultaneously in samples of very small volumes, such as
tears. No other techniques can measure so many cytokines in
individual basal human tear samples. Some of the detected
cytokine concentrations in our non-diabetic controls are in
agreement with the levels observed by other researchers using
similar multiplex bead analysis technique [22,25-27]. As in
other studies, some inconsistencies were also found compared
with these studies, i.e., we observed a higher level of PDGF-
BB,  IFN-γ,  FGF-b,  and  lower  VEGF  levels  compared  to
theirs. From our experience, the absolute concentration of a
given  cytokine  may  change  between  different  assay
techniques, but the trend of change in expression of each
cytokine under different pathological conditions remains the
same.  Inconsistencies  in  absolute  values  should  not
compromise the relative comparisons of individual cytokines
and their ratios among the different groups.
The cytokine recovery test of this assay showed that the
tear matrix did not interfere with the detection of most the
cytokines. Twenty out of the 27 cytokines could be reliably
detected in tears using this technique (recovery rate between
80%–120%).  The  recovery  rates  for  all  other  cytokines,
except for G-CSF, were between 53%–175%, which is also
acceptable.  The  only  cytokine  that  could  not  be  reliably
detected was G-CSF, with a recovery rate of 27%. Since this
cytokine did not show significant changes between the groups,
this assay defect should not compromise the significance of
this work.
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2934Figure 2. The ratios of anti-angiogenic cytokines (IFN-γ, IL-4, or
IL-12p70) and angiogenic cytokines (MCP-1, IL-8) in tears of non-
diabetic controls, DNR, and DR. Data was expressed as mean±SEM.
The asterisk indicatesd a p<0.05 DNR versus non-diabetic controls
and the dagger indicates a p<0.05 DR versus non-diabetic controls.
It  is  a  well  known  fact  that  collection  technique  can
influence the protein profile of a tear sample. Secretory IgA
is a constitutive tear protein and its level in non-stimulated
(open-eye or basal) tears is significantly higher than that in
stimulated (or reflex) tears, possibly due to the dilution effect
as a result of increased tear flow rate [28]. In the present study
significant  differences  were  found  for  tear  protein
concentrations  between  diabetic  patients  (with  or  without
retinopathy) and non-diabetic controls, but no difference for
IgA levels among the three groups was detected. These results
may indicate that our tear collection technique does not cause
the  production  of  reflex  tears,  or  the  level  of  reflex  tear
production caused by the capillary tubes was limited and
comparable among the subjects/groups. Thus the increased
levels of tear proteins in diabetic patients are not due to the
tear  collection  technique  and  may  result  from  some
pathological condition, such as leakage of blood components
caused by a sub-acute inflammatory reaction.
To the best of our knowledge, this is the first study to
measure 27 cytokines simultaneously in the tears of diabetic
patients. Significantly elevated tear MCP-1 and IP-10 levels
in  DR  and  DNR,  and  IL-1ra  levels  in  DNR  were  found
compared to those in non-diabetic controls. Pro-inflammatory
cytokines IP-10 and MCP-1 were also reported to be elevated
in the vitreous of patients with DR [10,11,29]. IL-1ra is an
anti-inflammatory factor that inhibits the pro-inflammatory
activity of IL-1β by competitively binding to the type 1 IL-1
receptor without triggering signal transduction [30]. Several
studies have suggested that an increase in IL-1ra production
could be a compensatory response to immuno-inflammatory
activation  present  at  diabetic  patients  [31,32].  Diabetic
patients  experience  damaged  corneal  epithelium  and
basement membranes due to abnormal glucose metabolism,
chronic  hypoxia,  and  altered  immune  status  at  the  ocular
surface [33,34].
Th1  cytokines  stimulate  cell-mediated  immunity,  and
promote inflammation and cytotoxicity. While Th2 cytokines
assure regulatory function, thus mediate protective function
during diabetes. In the current study, individual Th1 or Th2
cytokine levels were not significantly different among the
three groups. However, Th1/Th2 cytokine ratios of IFN-γ/
IL-5 and IL-2/IL-5 were significantly higher in DR than in
non-diabetic controls or DNR, suggesting that secretions of
TABLE 3. CORRELATIONS BETWEEN CONCENTRATION OF TEAR CYTOKINES AND DURATION OF DIABETES.
Cytokines Correlation coefficients p values
IL-2 −0.518 0.003
IL-4 −0.474 0.008
IL-7 −0.478 0.008
EOTAXIN −0.477 0.008
IFN-γ −0.474 0.008
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a Th1-dominant state. These data support the hypothesis that
Th1  cytokines  predominate  and  create  an  inflammatory
response in the pathogenesis of DR.
The two chemokines elevated in the tears of diabetics,
IP-10 and MCP-1, are potentially anti-angiogenic and pro-
angiogenic factors, respectively [35,36]. In addition, IFN-γ,
IL-4, and IL-12p70 have been reported to be anti-angiogenic,
while IL-8 is an angiogenic factor [37,38]. In the present
study,  the  ratios  of  IFN-γ/MCP-1  and  IL-4/MCP-1  were
decreased in patients with or without DR, and IFN-γ/IL-8,
IL-4/IL-8, and IL-12p70/IL-8 ratios were also decreased in
DR. These results suggest a pro-angiogenic environment in
the  tears  of  diabetics,  especially  those  with  retinopathy.
Aberrant  angiogensis  can  lead  to  formation  of  tube-like
structures  and  vascular  hyperpermeability,  resulting  in
leakage  of  plasma  proteins.  These  proteins  participate  in
extracellular matrix remodelling and tissue destruction, and
play a key role in inflammatory process at ocular surface of
diabetic patients [39].
IL-12  possesses  anti-angiogenic  activity,  mediated  by
stimulation of T-helper lymphocytes and induction of IP-10
expression  [38].  Conversely,  TNF-α  is  a  pro-angiogenic
mediator [40]. Disequilibrium between these pro- and anti-
angiogenic cytokines can promote late diabetic complications
[41]. Previous studies have shown that aging is associated
with  increased  levels  of  circulating  TNF-α  and  reduced
production of IL-12 [42-45]. In this study, the age range of the
patients  was  too  narrow  to  analyze  for  correlations.  No
correlations were observed between the concentrations of tear
cytokines and HbA1c or FPG in diabetic groups. This suggests
that inflammation at the ocular surface may not be directly
correlated to changes in metabolism commonly associated
with diabetes.
An interesting finding in this study is that certain tear
cytokines exhibited a negative correlation with duration of
diabetes. These results may indicate that in the initial stages
of  diabetes  there  are  major  changes  in  cytokine
concentrations. However, these changes seem to even out over
time. Netea et al. [45] reported an increase in plasma IL-1 and
a decrease in IL-1ra/IL-1 ratio in newly diagnosed type 1
diabetic patients, whereas IL-1 production in long-standing
type 1 diabetic patients did not differ from the control group.
However, it should be borne in mind that the duration of
diabetes  may  not  accurately  reflect  their  true  history  of
diabetes. Diabetes can often go under detected for several
years [46].
The diabetic condition affects the eye in many different
ways  due  to  peripheral  neuropathy  and  poor  metabolic
control,  which  can  result  in  dry  eye,  meibomian  gland
dysfunction,  reduction  of  corneal  sensibility  and  other
deleterious  characteristics  [37,47,48].  Any  of  these
complications can change cytokines profile in tears. Further
studies using more defined patient groups are needed to clarify
the contribution of each of these ocular complications to the
changes  in  cytokine  expression  observed.  While  some
differences in three cytokine levels were found between the
groups, these changes were less than twofold, lower than the
changes reported in other body fluid [49]. The changes in Th1/
Th2  cytokine  ratios  or  anti-angiogenic/pro-angiogenic
cytokines ratios were also relatively low. These results may
indicate that the ocular surface is not very vulnerable to this
destructive disease.
One limitation of our study is that the majority of patients
in DR group had non-proliferative DR (NPDR; 11 out of 15
patients). This may be the reason that no differences were
found  between  DNR  and  DR  for  any  of  cytokine
concentrations.  A  previous  study  demonstrated  that,  in
comparison with DNR, there were no significant changes in
tear  film  and  ocular  surface  in  patients  with  NPDR,  but
significant changes were found in patients with proliferative
DR (PDR) [47].
In  summary,  we  detected  elevated  pro-inflammatory
cytokines MCP-1 and IP-10, and a compensatory increase in
anti-inflammatory cytokine IL-1ra in tears of diabetic patients
with and without retinopathy. IFN-γ/IL-5 and IL-2/IL-5 ratios
were increased in tears of DR patients. Decreased ratios of
anti-angiogenic and angiogenic cytokines IFN-γ/MCP and
IL-4/MCP-1 in patients with and without DR, and IFN-γ/IL-8,
IL-4/IL-8,  and  IL-12p70/IL-8  in  DR  patients  were  also
observed.  These  results  demonstrate  that  chronic
inflammatory reaction and angiogenesis may occur at the
ocular surface of diabetic patients. Further studies are required
to  define  the  therapeutic  potential  of  cytokine-based
interventions  in  preventing  DR  or  other  diabetic  ocular
complications.
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